|
Characteristics
|
Number
|
No. of patients
|
P value
|
|---|
|
circAKT3high
|
circAKT3low
|
|---|
|
Age(y)
|
|
< 60
|
62
|
34
|
28
|
0.283
|
|
≥ 60
|
43
|
19
|
24
| |
|
Gender
|
|
Male
|
80
|
37
|
43
|
0.121
|
|
Female
|
25
|
16
|
9
| |
|
Tumor size(cm)
|
|
< 3.5
|
56
|
21
|
35
|
0.004**
|
|
≥ 3.5
|
49
|
32
|
17
| |
|
Histological grade
|
|
Well-moderately
|
33
|
11
|
22
|
0.017*
|
|
Poorly-signet
|
72
|
42
|
30
| |
|
Clinical stage
|
|
II
|
39
|
13
|
26
|
0.007**
|
|
III
|
66
|
40
|
26
| |
|
T classification
|
|
T1-T2
|
31
|
9
|
22
|
0.004**
|
|
T3-T4
|
74
|
44
|
30
| |
|
N classification
|
|
N0
|
14
|
5
|
9
|
0.232
|
|
N1-N3
|
91
|
48
|
43
| |
|
Cisplatin chemosensitivity
|
|
Sensitive
|
92
|
41
|
51
|
0.001**
|
|
Resistant
|
13
|
12
|
1
| |
